KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Pension (2016 - 2025)

Historic Pension for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Pfizer's Pension rose 405.21% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year increase of 405.21%. This contributed to the annual value of $2.1 billion for FY2024, which is 239.96% down from last year.
  • According to the latest figures from Q3 2025, Pfizer's Pension is $2.2 billion, which was up 405.21% from $2.1 billion recorded in Q2 2025.
  • Pfizer's 5-year Pension high stood at $4.5 billion for Q2 2021, and its period low was $2.0 billion during Q1 2025.
  • Its 5-year average for Pension is $2.7 billion, with a median of $2.2 billion in 2023.
  • As far as peak fluctuations go, Pfizer's Pension crashed by 3958.11% in 2022, and later skyrocketed by 441.18% in 2025.
  • Quarter analysis of 5 years shows Pfizer's Pension stood at $3.7 billion in 2021, then crashed by 39.58% to $2.2 billion in 2022, then decreased by 3.69% to $2.2 billion in 2023, then dropped by 2.4% to $2.1 billion in 2024, then rose by 1.99% to $2.2 billion in 2025.
  • Its last three reported values are $2.2 billion in Q3 2025, $2.1 billion for Q2 2025, and $2.0 billion during Q1 2025.